Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.6K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

973
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
973
Tonsillitis II: Management01:26

Tonsillitis II: Management

134
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
134
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

24
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
24

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential [<sup>11</sup>C]Acetate and [<sup>18</sup>F]FDG PET/CT Assessment of Systemic Chronic Active Epstein-Barr Virus Disease: An Exploratory Retrospective Study.

Diagnostics (Basel, Switzerland)·2026
Same author

Comparison of the effects of low-irradiance and high-irradiance phototherapy on non-hemolytic neonatal jaundice.

Scientific reports·2026
Same author

Response to recombinant human granulocyte colony-stimulating factor in reticular dysgenesis.

Journal of human immunity·2026
Same author

Efficacy and safety of multimodality therapy stratified by resection rate and molecular markers in children and adolescents with ependymoma: JCCG EPN23 protocol.

Japanese journal of clinical oncology·2026
Same author

Reticular Dysgenesis in an Extremely Low Birth Weight Infant: A Case Report.

Journal of clinical immunology·2026
Same author

Clinical features and prognostic factors of adult systemic chronic active EBV disease: A retrospective analysis in Japan.

British journal of haematology·2026

Related Experiment Video

Updated: Jul 16, 2025

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.2K

Updated guidelines for chronic active Epstein-Barr virus disease.

Jun-Ichi Kawada1, Yoshinori Ito2, Koichi Ohshima3

  • 1Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan. kawadaj@med.nagoya-u.ac.jp.

International Journal of Hematology
|September 20, 2023
PubMed
Summary

Updated guidelines for diagnosing and treating Chronic Active Epstein-Barr Virus Disease (CAEBV) emphasize confirming high Epstein-Barr virus (EBV) DNA loads and EBV-infected cells. Hematopoietic stem cell transplantation (HSCT) remains the only cure.

Keywords:
CAEBVDiagnostic criteriaEBVGuidelines

More Related Videos

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.0K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.3K

Related Experiment Videos

Last Updated: Jul 16, 2025

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.2K
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.0K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.3K

Area of Science:

  • Immunology
  • Virology
  • Hematology

Background:

  • Chronic Active Epstein-Barr Virus Disease (CAEBV) involves systemic inflammation and clonal proliferation of EBV-infected T or NK cells.
  • CAEBV is a life-threatening illness requiring timely diagnosis and intervention for better clinical outcomes.
  • Previous diagnostic guidelines for CAEBV have been updated to incorporate new evidence on pathogenesis and treatment.

Purpose of the Study:

  • To present updated guidelines for the diagnosis and treatment of CAEBV.
  • To improve the clinical management of CAEBV based on recent scientific evidence.
  • To provide clear diagnostic criteria and therapeutic recommendations for healthcare professionals.

Main Methods:

  • Review and synthesis of accumulated evidence on CAEBV pathogenesis and treatment.
  • Establishment of updated diagnostic criteria for CAEBV.
  • Identification of recommended therapeutic interventions.

Main Results:

  • Updated CAEBV diagnosis requires confirmation of high EBV genome copy number and EBV-infected T or NK cells.
  • An EBV DNA load ≥ 10,000 IU/mL in whole blood is proposed as the diagnostic cutoff.
  • Hematopoietic stem cell transplantation (HSCT) is identified as the only curative treatment, with chemotherapy used for pre-HSCT disease control.

Conclusions:

  • The updated guidelines provide a refined approach to CAEBV diagnosis, incorporating quantitative EBV DNA load measurements.
  • Hematopoietic stem cell transplantation (HSCT) is the definitive treatment for CAEBV.
  • Further research may lead to standardized treatment protocols beyond HSCT.